​
​

Inspira Technologies Oxy B.H.N. Stock (NASDAQ:IINN)

OwnershipFinancialsChart

Previous Close

$1.22

52W Range

$0.76 - $2.49

50D Avg

$1.31

200D Avg

$1.51

Market Cap

$23.68M

Avg Vol (3M)

$129.00K

Beta

2.09

Div Yield

-

IINN Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

37

IPO Date

Jul 14, 2021

Website

IINN Performance

IINN Financial Summary

Dec 23Dec 22Dec 21
Revenue-$-4.68M-
Operating Income$-12.13M$-14.77M$-13.43M
Net Income$-11.29M$-4.00M$-16.96M
EBITDA$-11.72M$-10.09M$-15.59M
Basic EPS$-0.93$-0.37$-3.20
Diluted EPS$-0.93$-0.37$-3.20

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
NURONeuroMetrix, Inc.
AIMDAinos, Inc.
SGHTSight Sciences, Inc.
LNSRLENSAR, Inc.
SSKNSTRATA Skin Sciences, Inc.
VAPOVapotherm, Inc.
TIVCTivic Health Systems, Inc.
IRIXIRIDEX Corporation
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
OPGNOpGen, Inc.
AZYOElutia Inc.
RSLSReShape Lifesciences Inc.
BBLGBone Biologics Corporation
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.
NAOVNanoVibronix, Inc.
VVOSVivos Therapeutics, Inc.